Mortality, disability, and intensive care in patients with mitochondrial 3243A>G mutation
Journal
Intensive Care Medicine
Journal Volume
41
Journal Issue
8
Pages
1493-1495
Date Issued
2015
Author(s)
Hsiue H.-C.
Yang C.-C.
Wu C.-S.
Hung K.-L.
Huang C.-C.
Chen C.-H.
Lin S.-J.
Chu S.-Y.
Wang T.-J.
Lu C.-J.
SDGs
Other Subjects
etiracetam; phenytoin; valproic acid; mitochondrial DNA; clinical article; cohort analysis; continuous renal replacement therapy; diabetic ketoacidosis; disability; disorders of mitochondrial functions; drug substitution; drug withdrawal; follow up; human; intensive care; lactic acidosis; length of stay; Letter; mortality; myopathy; Rankin scale; retrospective study; seizure; genetics; intensive care; MELAS syndrome; mortality; mutation; survival analysis; Taiwan; Cohort Studies; Critical Care; DNA, Mitochondrial; Humans; MELAS Syndrome; Mutation; Retrospective Studies; Survival Analysis; Taiwan
Publisher
Springer Verlag
Type
journal article